Just Announced: Tuesday Lunch Keynote at #MTC26
Join visionary industry leaders Mike Mahoney of Boston Scientific, Mick Farrell of Resmed, Ashley McEvoy of Insulet, and moderator John Babitt of EY at The MedTech Conference, October 18–21 in Boston, for a forward-looking discussion on where the greatest opportunities for value creation will emerge across medtech over the next two years.
This Tuesday Luncheon keynote will explore where the next wave of value creation in medtech is emerging, examining how leaders are leveraging AI-enabled innovation and connected technologies to strengthen competitiveness, adapting to the continued shift toward ambulatory surgical centers (ASCs), and using strategic mergers, acquisitions, and partnerships to shape portfolios, accelerate innovation, and drive long-term growth.
Attendees will hear how leading companies are:
- Moving AI beyond experimentation into scaled, workflow-embedded applications that support clinical decision-making, automate manual processes and improve patient engagement
- Integrating data, software and connected devices into core medtech platforms
- Responding to the continued shift toward ambulatory surgical centers and new care delivery models
- Using disciplined mergers, acquisitions and development strategies to accelerate innovation, shape stronger portfolios and deliver clear clinical and economic value
The Latest Medtech Business Strategy Insights, All In One Place
Business strategy is at the core of the #MTC26 education program. Across 12 interconnected tracks, medtech leaders will explore how innovation, investment, AI, commercialization, policy, and care delivery are reshaping the future of the industry.
With executives, investors, entrepreneurs, health systems, and industry partners all in one place, the conversations extend well beyond the session rooms, creating opportunities to build relationships, exchange ideas, and uncover new business opportunities.
Here are four sessions already generating excitement:
1. The Future of MedTech Innovation: Inside the Build-to-Buy Model
- Siddhartha Chadha, Partner, McKinsey & Company
- Donald Bobo Jr., Corporate Vice President, Strategy & Corporate Development, Edwards Lifesciences
- Todd Pope, Senior Partner, Revival Healthcare Capital
- Tim Schmid, EVP, Worldwide Chairman, MedTech, Johnson & Johnson MedTech
- Bob White, President and CEO, Olympus Corporation
2. Beyond the Device: Rethinking MedTech Through Ecosystems, Economics, and Enterprise Value
- Quentin Blackford, President and CEO, iRhythm Holdings
- Sean Cassidy, CEO and Co-Founder, Lucem Health
- Justin Klein, Co-Founder and Managing Partner, Vensana Capital
- Jeffery Wessler, MD, CEO, Heartbeat Health
3. Next-Generation Diagnostics: Tapping into the Global Need for Diagnostics for an Aging Population
- Alireza Atri, Chief Medical Officer and Banner Research Director, Banner Health
- David Kowalski, Head of IVD Consulting, IQVIA MedTech
- Ian Kremer, Executive Director, LEAD Coalition
- Maria-Magdalenda Patru, Senior Scientific Partner – Neurology, Roche Diagnostics
4. Working with Academia and Health Systems: A Playbook for Strategics and Startups
- Chris Coburn, Chief Innovation Officer, Mass General Hospital
- Lisa Carmel, Chair, Department of Business Development, Mayo Clinic
- Katie Reuther, PhD, MBA, Executive Director of Penn Health-Tech and Practice Professor of Bioengineering, University of Pennsylvania
- JaBaris Swain, MD, MPH, MBA, Director, Innovation, MedTech, Johnson & Johnson MedTech
These four sessions are just a preview of what you’ll find at #MTC26. With more than 400 expert speakers and 20+ timely topics, the education program delivers actionable insights on the trends, challenges, and opportunities shaping the future of medtech. Join industry leaders in Boston, October 18–21, and register before prices increase on August 6.